Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone. [PDF]
S R Ahmed+4 more
openalex +1 more source
Advances and Strategies in Enhancing mRNA Cancer Vaccines
Messenger RNA (mRNA) vaccines offer a powerful approach for cancer immunotherapy, but their clinical impact remains limited by delivery challenges and suboptimal immune activation. This review discusses key biological barriers and design strategies—including structural optimization, immunomodulation, organ targeting delivery, and advanced nanocarriers ...
Miao Zhang+4 more
wiley +1 more source
A novel electrochemical aptasensor enables the selective detection of lung cancer‐derived EVs by targeting the CD44 surface marker. The sensor uses a self‐assembled monolayer (SAM) for aptamer immobilization and achieves label‐free EV detection through electrochemical impedance spectroscopy.
Zarinah M. Amin+3 more
wiley +1 more source
Association of marginalization and PSMA-PET in prostate cancer An analysis of the Ontario PSMA-PET Registry for Recurrent Prostate Cancer. [PDF]
Tan VS+14 more
europepmc +1 more source
New Management Strategies of Hormone Refractory Prostate Cancer (HRPC)
MA Salam
openalex +2 more sources
Echogenicity of Prostate Cancer Correlated with Histologic Grade and Stromal Fibrosis: Endorectal US Studies [PDF]
openalex +1 more source
The study explores the influence of a tertiary amine in loading genetic material in a hybrid composite. The study highlights how structural attributes and chemical composition govern the crystallinity and cytocompatibility of ZIF‐biocomposites that effectively deliver nucleic acid to cancer cells.
Shakil Ahmed Polash+3 more
wiley +1 more source
Overdiagnosis and Overtreatment in Prostate Cancer. [PDF]
Dushimova Z+7 more
europepmc +1 more source
PROSTATE CANCER MANAGEMENT IN MOEWARDI HOSPITAL SURAKARTA FROM JANUARY 2000 – DECEMBER 2006
Endi Prilansa Mahadi, Suharto Widjanarko
openalex +1 more source
Heterogeneity Landscape of Circulating Tumor Cells in Clinical Utility
This study reports the heterogeneity spectrum of circulating tumor cells. The factors involved in the spectrum promote CTCs to overcome barriers in the metastatic cascade but impact the clinical outcome of cancer patients. In summary, the heterogeneities in association with CTCs ultimately reduce patient survival and facilitate increasing mortality of ...
Md Kowsar Alam+5 more
wiley +1 more source